Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of Gastric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT06585488
What this trial is testing

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

Who this might be right for
Metastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Colorectal Cancer+4 more
BeOne Medicines 47
Testing effectiveness (Phase 2)Ended earlyNCT00012246
What this trial is testing

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+4 more
The University of Texas Medical Branch, Galveston 7
Testing effectiveness (Phase 2)Study completedNCT00003298
What this trial is testing

Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
ECOG-ACRIN Cancer Research Group 39
Early research (Phase 1)Study completedNCT04336098
What this trial is testing

Study of SRF617 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Coherus Oncology, Inc. 85
Testing effectiveness (Phase 2)Study completedNCT01364493
What this trial is testing

Evaluate the Efficacy and Safety of Trastuzumab in Combination With Capecitabine and Oxaliplatin as First-line Chemotherapy for Inoperable, Locally Advanced or Recurrent and/or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University 51
Early research (Phase 1)WithdrawnNCT02205463
What this trial is testing

KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer

Who this might be right for
Esophageal CancerStomach Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Looking for participantsNCT07795749
What this trial is testing

Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)

Who this might be right for
Esophageal CarcinomaGastric Cancer (Diagnosis)Colorectal Adenocarcinoma+3 more
University of California, Irvine 55
Not applicableLooking for participantsNCT06881043
What this trial is testing

The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer

Who this might be right for
Locally Advanced Gastric CancerGastric Adenocarcinoma
The First Hospital of Jilin University 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06764251
What this trial is testing

Tislelizumab Combined with SOX Regimen in the Treatment of Locally Advanced Gastric Cancer/gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric/Gastroesophageal Junction Adenocarcinoma
Liaoning Cancer Hospital & Institute 20
Not applicableUnknownNCT03278327
What this trial is testing

Impact of an Endoscopic Treatment of the Line Z on the Gastronomic Recurrence and the Gastro- Esophageal Reflux Disease in the Care of the Adenocarcinoma of Barrett's Oesophagus

Who this might be right for
Barrett Esophagus Adenocarcinoma
Institut Paoli-Calmettes 30
Testing effectiveness (Phase 2)WithdrawnNCT03982173
What this trial is testing

Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors

Who this might be right for
Metastatic Colorectal CancerTriple Negative Breast CancerProstate Adenocarcinoma+2 more
Gustave Roussy, Cancer Campus, Grand Paris
Early research (Phase 1)Active Not RecruitingNCT05802056
What this trial is testing

Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Clinical Stage IV Gastric Cancer AJCC v8Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Mayo Clinic 15
Testing effectiveness (Phase 2)Study completedNCT00073502
What this trial is testing

Phase II Study of Single Agent OSI-7904L in Patients With Gastric or Gastroesophageal (GEJ) Cancer

Who this might be right for
Gastroesophageal AdenocarcinomaGastric Adenocarcinoma
OSI Pharmaceuticals 43
Early research (Phase 1)WithdrawnNCT05296005
What this trial is testing

Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers

Who this might be right for
Clinical Stage I Gastric Cancer AJCC v8Clinical Stage II Gastric Cancer AJCC v8Clinical Stage IIA Gastric Cancer AJCC v8+22 more
Ohio State University Comprehensive Cancer Center
Not applicableStudy completedNCT03123432
What this trial is testing

Immunomodulating Nutrients in Perioperative Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
Kaohsiung Medical University Chung-Ho Memorial Hospital 34
Large-scale testing (Phase 3)Looking for participantsNCT07431281
What this trial is testing

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaEsophageal Cancer
AstraZeneca 2,130
Testing effectiveness (Phase 2)Looking for participantsNCT07702292
What this trial is testing

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Who this might be right for
Colorectal CancerEpithelial Ovarian CancerGastric Cancer (GC)+2 more
Blue Earth Diagnostics 71
Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Testing effectiveness (Phase 2)UnknownNCT04341857
What this trial is testing

PD-1 Monoclonal Antibody Combined With FLOT Regimen for Neoadjuvant Therapy of Gastric Adenocarcinoma

Who this might be right for
Gastric and Esophagogastric Junction Adenocarcinoma
Henan Cancer Hospital 25
Testing effectiveness (Phase 2)UnknownNCT00004236
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer

Who this might be right for
Esophageal CancerGastric Cancer
University of Leicester
Next Page